H.R. 4534 — what changed

Women and Lung Cancer Research and Preventive Services Act of 2024

From Introduced in House to Reported in House. 2 sections amended and 2 removed between Introduced in House and Reported in House.

Section 1 Short title

changed This Act may be cited as the “Women and Lung Cancer Research and Preventive Services Act of 2023”.2024”.

Sec. 2 Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns

(a)

added In general— The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to—

(1)

added research on lung cancer in women;

(2)

added research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force;

(3)

added access to lung cancer preventive services; and

(4)

added strategic public awareness and education campaigns on lung cancer.

removed Congress finds as follows:

(b)

changed Content— According to the American Cancer Society, in the United States, approximately 164 women die each day of lung cancer, or about one woman every 8.8 minutes.The review and recommendations under subsection (a) shall include—

(1)

added a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government;

(2)

added opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—

(A)

added encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women;

(B)

added evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and

(C)

added foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities;

(3)

added opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and

(4)

added opportunities regarding the development of a national public education and awareness campaign on—

(A)

added lung cancer in women and underserved populations; and

(B)

added the importance of early detection of lung cancer.

(c)

changed Report— Lung cancer is Not later than two years after the leading cause date of cancer death among women.the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).

(3)

removed The American Cancer Society estimates that 59,910 women will die of lung cancer in 2023.

(4)

removed Studies have shown a higher incidence rate of lung cancer for women who were never smokers compared to men who were never smokers.

(5)

removed According to the American Cancer Society, new cases of lung cancer dropped by 3 percent per year in men from 2011 to 2015, while new cases in women only dropped 1.5 percent per year in the same time period.

(6)

removed According to the 2014 report, “The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014”, the relative risk of developing lung cancer increased tenfold among female smokers between 1959 and 2010.

(7)

removed According to the American Cancer Society, approximately 40 percent of lung cancers are adenocarcinoma, a subtype of non-small cell lung cancer, which is the most common type of cancer seen in non-smokers and is more common in women than in men.

(8)

removed According to the Environmental Protection Agency, exposure to radon accounts for approximately 21,000 deaths from lung cancer each year and is the second leading cause of lung cancer in nonsmokers.

(9)

removed A Government Accountability Office report published on October 22, 2015, called for the National Institutes of Health to do more in evaluating gender differences in research.

(10)

removed Additional research strategies, including clinical trials, are necessary to explore the differences in lung cancer risk factors, incidence, and treatment response in women, and to address the disparate impact of lung cancer on women who have never smoked.

(11)

removed Lung cancer screening, which can detect lung cancer at its earliest, most curable stage, is a covered service available without cost-sharing for those at high risk.

(12)

removed Published peer-reviewed actuarial studies indicate that lung cancer screening individuals at high risk may be cost-effective.

(13)

removed The National Framework of Excellence in Lung Cancer Screening and Continuum of Care, launched in 2012, demonstrated that lung cancer screening can be safely and effectively carried out in community hospital settings around the Nation.

(14)

removed Information on the impact of lung cancer on women and the importance of early detection should be incorporated into all relevant public health awareness campaigns.

Sec. 3 Sense of Congress concerning women and lung cancer

removed

removed It is the sense of Congress that—

(1)

removed there is a disparate impact of lung cancer on women and, in particular, on women who have never smoked;

(2)

removed additional research strategies to explore the differences in women with respect to lung cancer risk factors, incidence, histology, and response to treatment are justified and necessary;

(3)

removed the implementation of lung cancer preventive services for women should be accelerated; and

(4)

removed the public health agencies of the Federal Government should coordinate public education and awareness programs on the impact of lung cancer on women and the importance of early detection.

Sec. 4 Interagency review to evaluate and identify opportunities for the acceleration of research on women and lung cancer, greater access to preventive services, and strategic public awareness and education campaigns

removed

(a)

removed In general— The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to—

(1)

removed research on women and lung cancer;

(2)

removed access to lung cancer preventive services; and

(3)

removed strategic public awareness and education campaigns on lung cancer.

(b)

removed Content— The review and recommendations under subsection (a) shall include—

(1)

removed a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to women and lung cancer in all agencies of the Federal Government;

(2)

removed specific opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—

(A)

removed encourage innovative approaches to eliminate knowledge gaps in research;

(B)

removed evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and

(C)

removed foster advances in imaging technology to improve risk assessment, diagnosis, treatment, and the simultaneous application of other preventive services;

(3)

removed opportunities regarding the development of a national lung cancer screening strategy with sufficient infrastructure and personnel resources to expand access to such screening, particularly among underserved populations; and

(4)

removed opportunities regarding the development of a national public education and awareness campaign on women and lung cancer and the importance of early detection of lung cancer.

(c)

removed Report— Not later than one year after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).